{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:10:29Z","timestamp":1723075829475},"posted":{"date-parts":[[2023,1,9]]},"group-title":"In Review","reference-count":51,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,1,2]]},"abstract":"<title>Abstract<\/title>\n        <p>There is increasing evidence that the T-cell protein, Lck, is involved in the pathogenesis of chronic lymphocytic leukemia (CLL) as well as other leukemias and lymphomas. We previously discovered that Lck binds to domain 5 of inositol 1,4,5-trisphosphate receptors (IP3R) to regulate Ca2+ homeostasis. Using bioinformatics, we targeted a region within domain 5 of IP3R-1 predicted to facilitate protein-protein interactions (PPIs). We generated a synthetic 21 amino acid peptide, KKRMDLVLELKNNASKLLLAI, which constitutes a domain 5 sub-domain (D5SD) of IP3R-1 that specifically binds Lck via its SH2 domain. With the addition of an HIV-TAT sequence to enable cell permeability of D5SD peptide, we observed wide-spread, Ca2+-dependent, cell killing of hematological cancer cells when the Lck-IP3R PPI was disrupted by TAT-D5SD. All cell lines and primary cells were sensitive to D5SD peptide, but malignant T-cells were less sensitive compared with B-cell or myeloid malignancies. Mining of RNA-seq data showed that LCK was expressed in primary diffuse large B-cell lymphoma (DLBCL) as well as acute myeloid leukemia (AML). In fact, LCK shows a similar pattern of expression as many well-characterized AML oncogenes and is part of a protein interactome that includes FLT3-ITD, Notch-1, and Kit. Consistent with these findings, our data suggest that the Lck-IP3R PPI may protect malignant hematopoietic cells from death. Importantly, TAT-D5SD showed no cytotoxicity in three different non-hematopoietic cell lines; thus its ability to induce cell death appears specific to hematopoietic cells. Together, these data show that a peptide designed to disrupt the Lck-IP3R PPI has a wide range of pre-clinical activity in leukemia and lymphoma.<\/p>","DOI":"10.21203\/rs.3.rs-2436910\/v1","type":"posted-content","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T22:26:13Z","timestamp":1673303173000},"source":"Crossref","is-referenced-by-count":0,"title":["A novel peptide that disrupts the Lck-IP3R protein-protein interaction induces widespread cell death in leukemia and lymphoma"],"prefix":"10.21203","author":[{"given":"Michael","family":"Harr","sequence":"first","affiliation":[{"name":"Case Western Reserve University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Lavik","sequence":"additional","affiliation":[{"name":"Case Western Reserve University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"McColl","sequence":"additional","affiliation":[{"name":"Case Western Reserve University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Zhong","sequence":"additional","affiliation":[{"name":"Case Western Reserve University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Haberer","sequence":"additional","affiliation":[{"name":"Case Western Reserve University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadijah","family":"Aldabbagh","sequence":"additional","affiliation":[{"name":"Case Western Reserve University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivien","family":"Yee","sequence":"additional","affiliation":[{"name":"Case Western Reserve University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clark W.","family":"Distelhorst","sequence":"additional","affiliation":[{"name":"Case Western Reserve University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0092-8674(85)90169-2","article-title":"A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA","volume":"43","author":"Marth JD","year":"1985","unstructured":"Marth JD, Peet R, Krebs EG, Perlmutter RM. A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA. Cell. 1985;43:393\u2013404.","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/319682a0","article-title":"Expression of a new tyrosine protein kinase is stimulated by retrovirus promoter insertion","volume":"319","author":"Voronova AF","year":"1986","unstructured":"Voronova AF, Sefton BM. Expression of a new tyrosine protein kinase is stimulated by retrovirus promoter insertion. Nature. 1986;319:682\u2013685.","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.3390\/ijms20143500","article-title":"Beyond TCR Signaling: Emerging Functions of Lck in Cancer and Immunotherapy","volume":"20","author":"Bommhardt U","year":"2019","unstructured":"Bommhardt U, Schraven B, Simeoni L. Beyond TCR Signaling: Emerging Functions of Lck in Cancer and Immunotherapy. Int J Mol Sci. 2019;20:3500.","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/cdd.2010.25","article-title":"Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia","volume":"17","author":"Harr MW","year":"2010","unstructured":"Harr MW, Caimi PF, McColl KS, Zhong F, Patel SN, Barr PM, Distelhorst CW. Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia. Cell Death Differ. 2010;17:1381\u20131391.","journal-title":"Cell Death Differ"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3109\/10428199709050891","article-title":"Expression of p56lck in B-cell neoplasias","volume":"26","author":"Knethen A","year":"1997","unstructured":"Von Knethen A, Abts H, Kube D, Diehl V, Tesch H. Expression of p56lck in B-cell neoplasias. Leuk Lymphoma. 1997;26:551\u2013562.","journal-title":"Leuk Lymphoma"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0145-2126(91)90103-Z","article-title":"Human chronic lymphocytic leukemia cells regularly express mRNAs of the protooncogenes lck and c-fgr","volume":"15","author":"Abts H","year":"1991","unstructured":"Abts H, J\u00fccker M, Diehl V, Tesch H. Human chronic lymphocytic leukemia cells regularly express mRNAs of the protooncogenes lck and c-fgr. Leuk Res. 1991;15:987\u2013997.","journal-title":"Leuk Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41467-017-00830-y","article-title":"NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia","volume":"8","author":"M\u00e4rklin M","year":"2017","unstructured":"M\u00e4rklin M, Heitmann JS, Fuchs AR, et al. NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia. Nat Commun. 2017;8:755.","journal-title":"Nat Commun"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"16784","DOI":"10.1038\/s41598-017-17021-w","article-title":"Lck is a relevant target in chronic lymphocytic leukaemia cells whose expression variance is unrelated to disease outcome","volume":"7","author":"Till KJ","year":"2017","unstructured":"Till KJ, Allen JC, Talab F, et al. Lck is a relevant target in chronic lymphocytic leukaemia cells whose expression variance is unrelated to disease outcome. Sci Rep. 2017;7:16784.","journal-title":"Sci Rep"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1158\/1541-7786.MCR-12-0415-T","article-title":"LCK is an important mediator of B-cell receptor signaling in chronic lymphocytic leukemia cells","volume":"11","author":"Talab F","year":"2013","unstructured":"Talab F, Allen JC, Thompson V, Lin K, Slupsky JR. LCK is an important mediator of B-cell receptor signaling in chronic lymphocytic leukemia cells. Mol Cancer Res. 2013;11:541\u2013554.","journal-title":"Mol Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1182\/bloodadvances.2017015321","article-title":"Ectopic Lck expression in CLL demarcates intratumoral subpopulations with aberrant B-cell receptor signaling","volume":"2","author":"Theofani E","year":"2018","unstructured":"Theofani E, Alexis S, Costeas P, et al. Ectopic Lck expression in CLL demarcates intratumoral subpopulations with aberrant B-cell receptor signaling. Blood Adv. 2018;2:877\u2013882.","journal-title":"Blood Adv"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3324\/haematol.2015.139154","article-title":"SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course","volume":"101","author":"Dezorella N","year":"2016","unstructured":"Dezorella N, Katz BZ, Shapiro M, Polliack A, Perry C, Herishanu Y. SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course. Haematologica. 2016;101:1553\u20131562.","journal-title":"Haematologica"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev.immunol.021908.132550","article-title":"Molecular basis of calcium signaling in lymphocytes: STIM and ORAI","volume":"28","author":"Hogan PG","year":"2010","unstructured":"Hogan PG, Lewis RS, Rao A. Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu Rev Immunol. 2010;28:491\u2013533.","journal-title":"Annu Rev Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"31860","DOI":"10.1074\/jbc.M109.005579","article-title":"Glucocorticoid-mediated inhibition of Lck modulates the pattern of T cell receptor-induced calcium signals by down-regulating inositol 1,4,5-trisphosphate receptors","volume":"284","author":"Harr MW","year":"2009","unstructured":"Harr MW, Rong Y, Bootman MD, Roderick HL, Distelhorst CW. Glucocorticoid-mediated inhibition of Lck modulates the pattern of T cell receptor-induced calcium signals by down-regulating inositol 1,4,5-trisphosphate receptors. J Biol Chem. 2009;284:31860\u201331871.","journal-title":"J Biol Chem"},{"key":"ref14","first-page":"772","article-title":"The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas","volume":"91","author":"Paterson JC","year":"2006","unstructured":"Paterson JC, Tedoldi S, Craxton A, et al. The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas. Haematologica. 2006;91:772\u2013780.","journal-title":"Haematologica"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.leukres.2019.01.006","article-title":"Evidence for activated Lck protein tyrosine kinase as the driver of proliferation in acute myeloid leukemia cell, CTV-1","volume":"78","author":"Li L","year":"2019","unstructured":"Li L, Cui Y, Shen J el al. Evidence for activated Lck protein tyrosine kinase as the driver of proliferation in acute myeloid leukemia cell, CTV-1. Leuk Res. 2019; 78:12\u201320.","journal-title":"Leuk Res"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12032-015-0572-4","article-title":"Identification of potential therapeutic target genes, key miRNAs and mechanisms in acute myeloid leukemia based on bioinformatics analysis","volume":"32","author":"Zhao Y","year":"2015","unstructured":"Zhao Y, Zhang X, Zhao Y et al. Identification of potential therapeutic target genes, key miRNAs and mechanisms in acute myeloid leukemia based on bioinformatics analysis. Med Oncol. 2015; 32(5):152.","journal-title":"Med Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0076-6879(96)66034-0","article-title":"GOR method for predicting protein secondary structure from amino acid sequence","volume":"266","author":"Garnier J","year":"1996","unstructured":"Garnier J, Gibrat JF, Robson B. GOR method for predicting protein secondary structure from amino acid sequence. Methods Enzymol. 1996;266:540\u2013553.","journal-title":"Methods Enzymol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1006\/jmbi.1993.1413","article-title":"Prediction of protein secondary structure at better than 70% accuracy","volume":"232","author":"Rost B","year":"1993","unstructured":"Rost B, Sander C. Prediction of protein secondary structure at better than 70% accuracy. J Mol Biol. 1993;232:584\u2013599.","journal-title":"J Mol Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0014-5793(03)00456-3","article-title":"Predicted protein-protein interaction sites from local sequence information","volume":"544","author":"Ofran Y","year":"2003","unstructured":"Ofran Y, Rost B. Predicted protein-protein interaction sites from local sequence information. FEBS Lett. 2003;544:236\u2013239.","journal-title":"FEBS Lett"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"7990","DOI":"10.1038\/sj.onc.1208074","article-title":"Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation","volume":"23","author":"Palacios EH","year":"2004","unstructured":"Palacios EH, Weiss A. Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene. 2004;23:7990\u20138000.","journal-title":"Oncogene"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0092-8674(93)90404-E","article-title":"SH2 domains recognize specific phosphopeptide sequences","volume":"72","author":"Songyang Z","year":"1993","unstructured":"Songyang Z, Shoelson SE, Chaudhuri M, et al. SH2 domains recognize specific phosphopeptide sequences. Cell. 1993;72:767\u2013778.","journal-title":"Cell"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/gtc.12022","article-title":"Activity-based kinase profiling of approved tyrosine kinase inhibitors","volume":"18","author":"Kitagawa D","year":"2013","unstructured":"Kitagawa D, Yokota K, Gouda M, et al. Activity-based kinase profiling of approved tyrosine kinase inhibitors. Genes Cells. 2013;18:110\u2013122.","journal-title":"Genes Cells"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/imr.12738","article-title":"The B-cell receptor in control of tumor B-cell fitness: Biology and clinical relevance","volume":"288","author":"Casola S","year":"2019","unstructured":"Casola S, Perucho L, Tripodo C, et al. The B-cell receptor in control of tumor B-cell fitness: Biology and clinical relevance. Immunol Rev. 2019;288:198\u2013213.","journal-title":"Immunol Rev"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ajh.24282","article-title":"Chronic lymphocytic leukemia (CLL)-Then and now","volume":"91","author":"Rai KR","year":"2016","unstructured":"Rai KR, Jain P. Chronic lymphocytic leukemia (CLL)-Then and now. Am J Hematol. 2016;91:330\u2013340.","journal-title":"Am J Hematol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3390\/cancers12061396","article-title":"Mechanisms of B cell receptor activation and responses to B cell receptor inhibitors in B cell malignancies","volume":"12","author":"Efremov DG","year":"2020","unstructured":"Efremov DG, Turkalj S, Laurenti L. Mechanisms of B cell receptor activation and responses to B cell receptor inhibitors in B cell malignancies. Cancers (Basel). 2020;12:1396.","journal-title":"Cancers (Basel)"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-1-4939-1661-0_4","article-title":"A multiplexed method for kinetic measurements of apoptosis and proliferation using live-content imaging","volume":"1219","author":"Artymovich K","year":"2015","unstructured":"Artymovich K, Appledorn DM. A multiplexed method for kinetic measurements of apoptosis and proliferation using live-content imaging. Methods Mol Biol. 2015; 1219:35\u201342.","journal-title":"Methods Mol Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"13734","DOI":"10.1038\/s41598-017-14033-4","article-title":"The Src family kinase LCK cooperates with oncogenic FLT3\/ITD in cellular transformation","volume":"7","author":"Marh\u00e4ll A","year":"2017","unstructured":"Marh\u00e4ll A, Kazi JU, R\u00f6nnstrand L. The Src family kinase LCK cooperates with oncogenic FLT3\/ITD in cellular transformation. Sci Rep. 2017;7:13734.","journal-title":"Sci Rep"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41392-020-00315-3","article-title":"Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials","volume":"5","author":"Lu H","year":"2020","unstructured":"Lu H, Zhou Q, He J, et al. Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials. Signal Transduct Target Ther. 2020;5:213.","journal-title":"Signal Transduct Target Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fimmu.2012.00167","article-title":"How does the kinase Lck phosphorylate the T cell receptor? Spatial organization as a regulatory mechanism","volume":"3","author":"Rossy J","year":"2012","unstructured":"Rossy J, Williamson DJ, Gaus K. How does the kinase Lck phosphorylate the T cell receptor? Spatial organization as a regulatory mechanism. Front Immunol. 2012;3:167.","journal-title":"Front Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1074\/jbc.271.3.1295","article-title":"Demonstration of a direct interaction between p56lck and the cytoplasmic domain of CD45 in vitro","volume":"271","author":"Ng DH","year":"1996","unstructured":"Ng DH, Watts JD, Aebersold R, Johnson P. Demonstration of a direct interaction between p56lck and the cytoplasmic domain of CD45 in vitro. J Biol Chem. 1996;271:1295\u20131300.","journal-title":"J Biol Chem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-0854.2011.01286.x","article-title":"The ins and outs of HIV-1 Tat","volume":"13","author":"Debaisieux S","year":"2012","unstructured":"Debaisieux S, Rayne F, Yezid H, Beaumelle B. The ins and outs of HIV-1 Tat. Traffic. 2012;13:355\u2013363.","journal-title":"Traffic"},{"key":"ref32","first-page":"a005579","article-title":"Apoptosis and autophagy: decoding calcium signals that mediate life or death","volume":"2","author":"Harr MW","year":"2010","unstructured":"Harr MW, Distelhorst CW. Apoptosis and autophagy: decoding calcium signals that mediate life or death. Cold Spring Harb Perspect Biol. 2010;2:a005579.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1158\/1541-7786.MCR-17-0731","article-title":"Recognition of recurrent protein expression patterns in pediatric acute myeloid leukemia identified new therapeutic targets","volume":"16","author":"Hoff FW","year":"2018","unstructured":"Hoff FW, Hu CW, Qiu Y, et al. Recognition of recurrent protein expression patterns in pediatric acute myeloid leukemia identified new therapeutic targets. Mol Cancer Res. 2018;16:1275\u20131286.","journal-title":"Mol Cancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41375-018-0327-2","article-title":"Dasatinib and navitoclax act synergistically to target NUP98-NSD1+\/FLT3-ITD + acute myeloid leukemia","volume":"33","author":"Kivioja JL","year":"2019","unstructured":"Kivioja JL, Thanasopoulou A, Kumar A, et al. Dasatinib and navitoclax act synergistically to target NUP98-NSD1+\/FLT3-ITD + acute myeloid leukemia. Leukemia. 2019;33:1360\u20131372.","journal-title":"Leukemia"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"119206","DOI":"10.1016\/j.bbamcr.2021.119206","article-title":"A non-canonical role for pyruvate kinase M2 as a functional modulator of Ca2+ signalling through IP3 receptors","volume":"1869","author":"Lavik AR","year":"2022","unstructured":"Lavik AR, McColl KS, Lemos FO, et al. A non-canonical role for pyruvate kinase M2 as a functional modulator of Ca2+ signalling through IP3 receptors. Biochim Biophys Acta Mol Cell Res. 2022;1869:119206.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau K","year":"2015","unstructured":"Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discov Today. 2015;20:122\u2013128.","journal-title":"Drug Discov Today"},{"key":"ref37","unstructured":"Surveillance Epidemiology and End Results Program. Acute Myeloid Leukemia: Recent trends in SEER relative survival rates, 2000\u20132016. National Cancer Institute; Bethesda, MD: seer.cancer.gov. Accessed April 4, 2021."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1083\/jcb.200506189","article-title":"Bcl-2 differentially regulates Ca2+ signals according to the strength of T cell receptor activation","volume":"172","author":"Zhong F","year":"2006","unstructured":"Zhong F, Davis MC, McColl KS, Distelhorst CW. Bcl-2 differentially regulates Ca2+ signals according to the strength of T cell receptor activation. J Cell Biol. 2006;172:127\u2013137.","journal-title":"J Cell Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1093\/bioinformatics\/btx521","article-title":"ALIGNSEC: viewing protein secondary structure predictions within large multiple sequence alignments","volume":"33","author":"Del\u00e9age G","year":"2017","unstructured":"Del\u00e9age G. ALIGNSEC: viewing protein secondary structure predictions within large multiple sequence alignments. Bioinformatics. 2017;33:3991\u20133992.","journal-title":"Bioinformatics"},{"issue":"W1","key":"ref40","first-page":"W431-W435","article-title":"GalaxyPepDock: a protein-peptide docking tool based on interaction similarity and energy optimization","volume":"43","author":"Lee H","year":"2015","unstructured":"Lee H, Heo L, Lee MS, Seok C. GalaxyPepDock: a protein-peptide docking tool based on interaction similarity and energy optimization. Nucleic Acids Res. 2015;43(W1):W431-W435.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"ref41","first-page":"D1351-D1357","article-title":"PINA 3.0: mining cancer interactome","volume":"49","author":"Du Y","year":"2021","unstructured":"Du Y, Cai M, Xing X, Ji J, Yang E, Wu J. PINA 3.0: mining cancer interactome. Nucleic Acids Res. 2021;49(D1):D1351-D1357.","journal-title":"Nucleic Acids Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"W556-W560","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang Z","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47:W556-W560.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"ref43","first-page":"D77-D83","article-title":"Expression Atlas update: from tissues to single cells","volume":"48","author":"Papatheodorou I","year":"2020","unstructured":"Papatheodorou I, Moreno P, Manning J, et al. Expression Atlas update: from tissues to single cells. Nucleic Acids Res. 2020;48(D1):D77-D83.","journal-title":"Nucleic Acids Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nature13302","article-title":"A draft map of the human proteome","volume":"509","author":"Kim MS","year":"2014","unstructured":"Kim MS, Pinto SM, Getnet D, et al. A draft map of the human proteome. Nature. 2014;509:575\u2013581.","journal-title":"Nature"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41590-018-0131-1","article-title":"Lck promotes Zap70-dependent LAT phosphorylation by bridging Zap70 to LAT","volume":"19","author":"Lo WL","year":"2018","unstructured":"Lo WL, Shah NH, Ahsan N, et al. Lck promotes Zap70-dependent LAT phosphorylation by bridging Zap70 to LAT. Nat Immunol. 2018;19:733\u2013741.","journal-title":"Nat Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1476-4598-8-132","article-title":"Anomalous constitutive Src kinase activity promotes B lymphoma survival and growth","volume":"8","author":"Ke J","year":"2009","unstructured":"Ke J, Chelvarajan RL, Sindhava V, et al. Anomalous constitutive Src kinase activity promotes B lymphoma survival and growth. Mol Cancer. 2009;8:132.","journal-title":"Mol Cancer"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"22632","DOI":"10.1074\/jbc.270.38.22632","article-title":"Association of 75\/80-kDa phosphoproteins and the tyrosine kinases Lyn, Fyn, and Lck with the B cell molecule CD20. Evidence against involvement of the cytoplasmic regions of CD20","volume":"270","author":"Deans JP","year":"1995","unstructured":"Deans JP, Kalt L, Ledbetter JA, Schieven GL, Bolen JB, Johnson P. Association of 75\/80-kDa phosphoproteins and the tyrosine kinases Lyn, Fyn, and Lck with the B cell molecule CD20. Evidence against involvement of the cytoplasmic regions of CD20. J Biol Chem. 1995;270:22632\u201322638.","journal-title":"J Biol Chem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood-2008-06-161539","article-title":"CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure","volume":"113","author":"Fiegl M","year":"2009","unstructured":"Fiegl M, Samudio I, Clise-Dwyer K, Burks JK, Mnjoyan Z, Andreeff M. CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure. Blood. 2009;113:1504\u20131512.","journal-title":"Blood"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/leu.2009.267","article-title":"Dasatinib promotes ATRA-induced differentiation of AML cells","volume":"24","author":"Kropf PL","year":"2010","unstructured":"Kropf PL, Wang L, Zang Y, Redner RL, Johnson DE. Dasatinib promotes ATRA-induced differentiation of AML cells. Leukemia. 2010;24:663\u2013665.","journal-title":"Leukemia"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"27346","DOI":"10.18632\/oncotarget.25213","article-title":"Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitors","volume":"9","author":"Rupniewska E","year":"2018","unstructured":"Rupniewska E, Roy R, Mauri FA, et al. Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitors. Oncotarget. 2018;9:27346\u201327362.","journal-title":"Oncotarget"},{"issue":"19","key":"ref51","doi-asserted-by":"crossref","first-page":"12754","DOI":"10.1074\/jbc.272.19.12754","article-title":"Reconstitution of interactions between protein-tyrosine phosphatase CD45 and tyrosine-protein kinase p56(lck) in nonlymphoid cells","volume":"272","author":"Gervais FG","year":"1997","unstructured":"Gervais FG, Veillette A. Reconstitution of interactions between protein-tyrosine phosphatase CD45 and tyrosine-protein kinase p56(lck) in nonlymphoid cells. J Biol Chem. 1997;272(19):12754\u201312761.","journal-title":"J Biol Chem"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2436910\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2436910\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T15:17:13Z","timestamp":1723043833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2436910\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":51,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-2436910\/v1","relation":{},"subject":[],"published":{"date-parts":[[2023,1,9]]},"subtype":"preprint"}}